{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:59Z","timestamp":1791928679965,"version":"4.3.4"},"reference-count":73,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,9,12]]},"DOI":"10.1167\/iovs.18-24284","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T15:41:59Z","timestamp":1536766919000},"page":"4531","source":"Crossref","is-referenced-by-count":13,"title":["Low-Level Nighttime Light Therapy for Age-Related Macular Degeneration: A Randomized Clinical Trial"],"prefix":"10.1167","volume":"59","author":[{"given":"D. Grant","family":"Robinson","sequence":"first","affiliation":[{"name":"School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H.","family":"Margrain","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J.","family":"Dunn","sequence":"additional","affiliation":[{"name":"School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Bailey","sequence":"additional","affiliation":[{"name":"Bristol Eye Hospital, Lower Maudlin Street, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Binns","sequence":"additional","affiliation":[{"name":"Division of Optometry and Visual Science, School of Health Sciences, City, University of London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-11-4531-b01","doi-asserted-by":"crossref","unstructured":"Feigl B. Age-related maculopathy\u2014linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res. 2009; 28: 63\u201386.","DOI":"10.1016\/j.preteyeres.2008.11.004"},{"key":"i1552-5783-59-11-4531-b02","doi-asserted-by":"crossref","unstructured":"Stef\u00e1nsson E, Geirsd\u00f3ttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res. 2011; 30: 72\u201380.","DOI":"10.1016\/j.preteyeres.2010.09.003"},{"key":"i1552-5783-59-11-4531-b03","doi-asserted-by":"crossref","unstructured":"Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol. 2003; 121: 547\u2013557.","DOI":"10.1001\/archopht.121.4.547"},{"key":"i1552-5783-59-11-4531-b04","unstructured":"Ahmed J, Braun R, Dunn R, Linsenmeier R. Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci. 1993; 34: 516\u2013521."},{"key":"i1552-5783-59-11-4531-b05","doi-asserted-by":"crossref","unstructured":"Hagins W, Ross P, Tate R, Yoshikami S. Transduction heats in retinal rods: tests of the role of cGMP by pyroelectric calorimetry. Proc Natl Acad Sci U S A. 1989; 86: 1224\u20131228.","DOI":"10.1073\/pnas.86.4.1224"},{"key":"i1552-5783-59-11-4531-b06","doi-asserted-by":"crossref","unstructured":"Ciulla TA, Harris A, Chung H, et al. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol. 1999; 128: 75\u201380.","DOI":"10.1016\/S0002-9394(99)00061-6"},{"key":"i1552-5783-59-11-4531-b07","doi-asserted-by":"crossref","unstructured":"Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci. 2005; 46: 1033\u20131038.","DOI":"10.1167\/iovs.04-1050"},{"key":"i1552-5783-59-11-4531-b08","doi-asserted-by":"crossref","unstructured":"Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008; 49: 358\u2013363.","DOI":"10.1167\/iovs.07-0526"},{"key":"i1552-5783-59-11-4531-b09","doi-asserted-by":"crossref","unstructured":"Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007; 48: 968\u2013977.","DOI":"10.1167\/iovs.06-0443"},{"key":"i1552-5783-59-11-4531-b10","doi-asserted-by":"crossref","unstructured":"Booij JC, Baas DC, Beisekeeva J, Gorgels T, Bergen A. The dynamic nature of Bruch's membrane. Prog Retin Eye Res. 2010; 29: 1\u201318.","DOI":"10.1016\/j.preteyeres.2009.08.003"},{"key":"i1552-5783-59-11-4531-b11","doi-asserted-by":"crossref","unstructured":"McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009; 50: 4982\u20134991.","DOI":"10.1167\/iovs.09-3639"},{"key":"i1552-5783-59-11-4531-b12","doi-asserted-by":"crossref","unstructured":"Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996; 37: 1929\u20131934.","DOI":"10.1016\/S0002-9394(14)70522-7"},{"key":"i1552-5783-59-11-4531-b13","unstructured":"Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996; 37: 855\u2013868."},{"key":"i1552-5783-59-11-4531-b14","doi-asserted-by":"crossref","unstructured":"Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D. Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol. 2009; 247: 1361\u20131367.","DOI":"10.1007\/s00417-009-1133-3"},{"key":"i1552-5783-59-11-4531-b15","doi-asserted-by":"crossref","unstructured":"Inoue Y, Yanagi Y, Matsuura K, Takahashi H, Tamaki Y, Araie M. Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol. 2007; 91: 1720\u20131721.","DOI":"10.1136\/bjo.2006.111583"},{"key":"i1552-5783-59-11-4531-b16","doi-asserted-by":"crossref","unstructured":"Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmol. 2001; 108: 1196\u20131202.","DOI":"10.1016\/S0161-6420(01)00580-2"},{"key":"i1552-5783-59-11-4531-b17","doi-asserted-by":"crossref","unstructured":"Gaffney AJ, Binns AM, Margrain TH. Topography of cone dark adaptation deficits in age-related maculopathy. Optom Vis Sci. 2011; 88: 1080\u20131087.","DOI":"10.1097\/OPX.0b013e3182223697"},{"key":"i1552-5783-59-11-4531-b18","doi-asserted-by":"crossref","unstructured":"O'Neill-Biba M, Sivaprasad S, Rodriguez-Carmona M, Wolf J, Barbur J. Loss of chromatic sensitivity in AMD and diabetes: a comparative study. Ophthalmic Physiol Opt. 2010; 30: 705\u2013716.","DOI":"10.1111\/j.1475-1313.2010.00775.x"},{"key":"i1552-5783-59-11-4531-b19","unstructured":"Mayer M, Spiegler S, Ward B, Glucs A, Kim C. Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci. 1992; 33: 3136\u20133142."},{"key":"i1552-5783-59-11-4531-b20","unstructured":"Mayer M, Spiegler S, Ward B, Glucs A, Kim C. Foveal flicker sensitivity discriminates ARM-risk from healthy eyes. Invest Ophthalmol Vis Sci. 1992; 33: 3143\u20133149."},{"key":"i1552-5783-59-11-4531-b21","doi-asserted-by":"crossref","unstructured":"Dimitrov PN, Robman LD, Varsamidis M, et al. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011; 52: 9457\u20139469.","DOI":"10.1167\/iovs.10-7043"},{"key":"i1552-5783-59-11-4531-b22","doi-asserted-by":"crossref","unstructured":"Feigl B, Stewart I, Brown B. Experimental hypoxia in human eyes: implications for ischaemic disease. Clin Neurophysiol. 2007; 118: 887\u2013895.","DOI":"10.1016\/j.clinph.2006.12.012"},{"key":"i1552-5783-59-11-4531-b23","doi-asserted-by":"crossref","unstructured":"Pavlidis M, Stupp T, Georgalas I, Georgiadou E, Moschos M, Thanos S. Multifocal electroretinography changes in the macula at high altitude: a report of three cases. Ophthalmologica. 2005; 219: 404\u2013412.","DOI":"10.1159\/000088387"},{"key":"i1552-5783-59-11-4531-b24","doi-asserted-by":"crossref","unstructured":"Connolly DM, Hosking SL. Aviation-related respiratory gas disturbances affect dark adaptation: a reappraisal. Vision Res. 2006; 46: 1784\u20131793.","DOI":"10.1016\/j.visres.2005.10.027"},{"key":"i1552-5783-59-11-4531-b25","unstructured":"Karakucuk S, Oner AO, Goktas S, Siki E, Kose O. Color vision changes in young subjects acutely exposed to 3,000 m altitude. Aviat Space Environ Med. 2004; 75: 364\u2013366."},{"key":"i1552-5783-59-11-4531-b26","doi-asserted-by":"crossref","unstructured":"Vingrys AJ, Garner LF. The effect of a moderate level of hypoxia on human color vision. Doc Ophthalmol. 1987; 66: 171\u2013185.","DOI":"10.1007\/BF00140454"},{"key":"i1552-5783-59-11-4531-b27","doi-asserted-by":"crossref","unstructured":"Arden G, G\u00fcnd\u00fcz M, Kurtenbach A, et al. A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy. Eye. 2010; 24: 1149\u20131155.","DOI":"10.1038\/eye.2009.328"},{"key":"i1552-5783-59-11-4531-b28","doi-asserted-by":"crossref","unstructured":"Sahni JN, Czanner G, Gutu T, et al. Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease. Eye. 2017; 31: 97\u2013106.","DOI":"10.1038\/eye.2016.259"},{"key":"i1552-5783-59-11-4531-b29","doi-asserted-by":"crossref","unstructured":"Arden G, Jyothi S, Hogg C, Lee Y, Sivaprasad S. Regression of early diabetic macular oedema is associated with prevention of dark adaptation. Eye. 2011; 25: 1546\u20131554.","DOI":"10.1038\/eye.2011.264"},{"key":"i1552-5783-59-11-4531-b30","doi-asserted-by":"crossref","unstructured":"McKeague C, Margrain TH, Bailey C, Binns AM. Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial. Trials. 2014; 15: 246.","DOI":"10.1186\/1745-6215-15-246"},{"key":"i1552-5783-59-11-4531-b31","doi-asserted-by":"crossref","unstructured":"Margrain TH, Nollett C, Shearn J, et al. The Depression in Visual Impairment Trial (DEPVIT): trial design and protocol. BMC Psychiatry. 2012; 12: 57.","DOI":"10.1186\/1471-244X-12-57"},{"key":"i1552-5783-59-11-4531-b32","doi-asserted-by":"crossref","unstructured":"Stelmack JA, Szlyk JP, Stelmack TR, et al. Psychometric properties of the Veterans Affairs low-vision visual functioning questionnaire. Invest Ophthalmol Vis Sci. 2004; 45: 3919\u20133928.","DOI":"10.1167\/iovs.04-0208"},{"key":"i1552-5783-59-11-4531-b33","doi-asserted-by":"crossref","unstructured":"EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16: 199\u2013208.","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"i1552-5783-59-11-4531-b34","doi-asserted-by":"crossref","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28: 193\u2013213.","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"i1552-5783-59-11-4531-b35","doi-asserted-by":"crossref","unstructured":"McKeague C, Binns AM, Margrain TH. An evaluation of two candidate functional biomarkers for AMD. Optom Vis Sci. 2014; 91: 916\u2013924.","DOI":"10.1097\/OPX.0000000000000318"},{"key":"i1552-5783-59-11-4531-b36","doi-asserted-by":"crossref","unstructured":"Ferris F, Davis M, Clemons T, et al. A simplified severity scale for age-related macular degeneration. Arch Ophthalmol 2005; 123: 1570\u20131574.","DOI":"10.1001\/archopht.123.11.1570"},{"key":"i1552-5783-59-11-4531-b37","doi-asserted-by":"crossref","unstructured":"Moseley M, Bayliss S, Fielder A. Light transmission through the human eyelid: in vivo measurement. Ophthalmic Physiol Opt. 1988; 8: 229\u2013230.","DOI":"10.1111\/j.1475-1313.1988.tb01043.x"},{"key":"i1552-5783-59-11-4531-b38","doi-asserted-by":"crossref","unstructured":"Robinson J, Bayliss S, Fielder A. Transmission of light across the adult and neonatal eyelid in vivo. Vision Res. 1991; 31: 1837\u20131840.","DOI":"10.1016\/0042-6989(91)90031-Y"},{"key":"i1552-5783-59-11-4531-b39","doi-asserted-by":"crossref","unstructured":"Ando K, Kripke D. Light attenuation by the human eyelid. Biol Psychiatry. 1996; 39: 22\u201325.","DOI":"10.1016\/0006-3223(95)00109-3"},{"key":"i1552-5783-59-11-4531-b40","unstructured":"Winn B, Whitaker D, Elliott D, Phillips N. Factors affecting light-adapted pupil size in normal human subjects. Invest Ophthalmol Vis Sci. 1994; 35: 1132\u20131137."},{"key":"i1552-5783-59-11-4531-b41","doi-asserted-by":"crossref","unstructured":"Gregori G, Wang F, Rosenfeld PJ, et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology. 2011; 118: 1373\u20131379.","DOI":"10.1016\/j.ophtha.2010.11.013"},{"key":"i1552-5783-59-11-4531-b42","doi-asserted-by":"crossref","unstructured":"Roberts C, Torgerson D. Understanding controlled trials: baseline imbalance in randomised controlled trials. BMJ. 1999; 319: 185.","DOI":"10.1136\/bmj.319.7203.185"},{"key":"i1552-5783-59-11-4531-b43","doi-asserted-by":"crossref","unstructured":"Egbewale BE. Statistical issues in randomised controlled trials: a narrative synthesis. Asian Pac J Trop Biomed. 2015; 5: 354\u2013359.","DOI":"10.1016\/S2221-1691(15)30367-1"},{"key":"i1552-5783-59-11-4531-b44","doi-asserted-by":"crossref","unstructured":"Stelmack JA, Massof RW. Using the VA LV VFQ-48 and LV VFQ-20 in low vision rehabilitation. Optom Vis Sci. 2007; 84: 705\u2013709.","DOI":"10.1097\/OPX.0b013e3181339f1a"},{"key":"i1552-5783-59-11-4531-b45","doi-asserted-by":"crossref","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997; 35: 1095\u20131108.","DOI":"10.1097\/00005650-199711000-00002"},{"key":"i1552-5783-59-11-4531-b46","doi-asserted-by":"crossref","unstructured":"Rabin R, Charro F de. EQ-SD: a measure of health status from the EuroQol Group. Ann Med. 2001; 33: 337\u2013343.","DOI":"10.3109\/07853890109002087"},{"key":"i1552-5783-59-11-4531-b47","doi-asserted-by":"crossref","unstructured":"Sullivan GM, Artino AR Jr. Analyzing and interpreting data from Likert-type scales. J Grad Med Educ. 2013; 5: 541\u2013542.","DOI":"10.4300\/JGME-5-4-18"},{"key":"i1552-5783-59-11-4531-b48","doi-asserted-by":"crossref","unstructured":"Norman G. Likert scales, levels of measurement and the \u201claws\u201d of statistics. Adv Health Sci Educ Theory Pract. 2010; 15: 625\u2013632.","DOI":"10.1007\/s10459-010-9222-y"},{"key":"i1552-5783-59-11-4531-b49","doi-asserted-by":"crossref","unstructured":"Carifio J, Perla R. Resolving the 50-year debate around using and misusing Likert scales. Med Educ. 2008; 42: 1150\u20131152.","DOI":"10.1111\/j.1365-2923.2008.03172.x"},{"key":"i1552-5783-59-11-4531-b50","unstructured":"De Winter J, Dodou D. Five-point Likert items: t test versus Mann-Whitney-Wilcoxon. Practical Assessment, Research & Evaluation. 2010; 15: 10781922."},{"key":"i1552-5783-59-11-4531-b51","doi-asserted-by":"crossref","unstructured":"Chylack LT, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. Arch Ophthalmol. 1993; 111: 831\u2013836.","DOI":"10.1001\/archopht.1993.01090060119035"},{"key":"i1552-5783-59-11-4531-b52","unstructured":"Eisner A, Fleming SA, Klein ML, Mauldin WM. Sensitivities in older eyes with good acuity: eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci. 1987; 28: 1832\u20131837."},{"key":"i1552-5783-59-11-4531-b53","unstructured":"Eisner A, Stoumbos V, Klein M, Fleming S. Relations between fundus appearance and function: eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1991; 32: 8\u201320."},{"key":"i1552-5783-59-11-4531-b54","unstructured":"Midena E, Degli Angeli C, Blarzino M, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997; 38: 469\u2013477."},{"key":"i1552-5783-59-11-4531-b55","doi-asserted-by":"crossref","unstructured":"Owsley C, McGwin G, Jackson GR, Kallies K, Clark M. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmol. 2007; 114: 1728\u20131735.","DOI":"10.1016\/j.ophtha.2006.12.023"},{"key":"i1552-5783-59-11-4531-b56","doi-asserted-by":"crossref","unstructured":"Owsley C, McGwin G, Clark ME, et al. Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration. Ophthalmol. 2016; 123: 344\u2013351.","DOI":"10.1016\/j.ophtha.2015.09.041"},{"key":"i1552-5783-59-11-4531-b57","doi-asserted-by":"crossref","unstructured":"Binns AM, Margrain TH. Evaluating retinal function in age-related maculopathy with the ERG Photostress Test. Invest Ophthalmol Vis Sci. 2007; 48: 2806\u20132813.","DOI":"10.1167\/iovs.06-0392"},{"key":"i1552-5783-59-11-4531-b58","doi-asserted-by":"crossref","unstructured":"Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci. 2008; 49: 55\u201365.","DOI":"10.1167\/iovs.06-1048"},{"key":"i1552-5783-59-11-4531-b59","doi-asserted-by":"crossref","unstructured":"Dimitrov PN, Robman LD, Varsamidis M, et al. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012; 53: 5213\u20135220.","DOI":"10.1167\/iovs.11-8958"},{"key":"i1552-5783-59-11-4531-b60","doi-asserted-by":"crossref","unstructured":"Jackson G, Clark M, Scott I, Walter L, Quillen D, Brigell M. Twelve-month natural history of dark adaptation in patients with AMD. Optom Vis Sci. 2014; 91: 925\u2013931.","DOI":"10.1097\/OPX.0000000000000247"},{"key":"i1552-5783-59-11-4531-b61","unstructured":"Eisner A, Klein M, Zilis J, Watkins M. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1992; 33: 3091\u20133102."},{"key":"i1552-5783-59-11-4531-b62","doi-asserted-by":"crossref","unstructured":"Owsley C, Clark ME, McGwin G. Natural history of rod-mediated dark adaptation over 2 years in intermediate age-related macular degeneration. Trans Vis Sci Tech. 2017; 6 (3): 15.","DOI":"10.1167\/tvst.6.3.15"},{"key":"i1552-5783-59-11-4531-b63","doi-asserted-by":"crossref","unstructured":"Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight. Neuron. 2002; 36: 69\u201380.","DOI":"10.1016\/S0896-6273(02)00912-1"},{"key":"i1552-5783-59-11-4531-b64","doi-asserted-by":"crossref","unstructured":"Wang JS, Kefalov VJ. The cone-specific visual cycle. Prog Retin Eye Res. 2011; 30: 115\u2013128.","DOI":"10.1016\/j.preteyeres.2010.11.001"},{"key":"i1552-5783-59-11-4531-b65","doi-asserted-by":"crossref","unstructured":"Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003; 44: 2277\u20132283.","DOI":"10.1167\/iovs.02-0769"},{"key":"i1552-5783-59-11-4531-b66","doi-asserted-by":"crossref","unstructured":"Mata NL, Lichter JB, Vogel R, Han Y, Bui TV, Singerman LJ. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Retina. 2013; 33: 498\u2013507.","DOI":"10.1097\/IAE.0b013e318265801d"},{"key":"i1552-5783-59-11-4531-b67","doi-asserted-by":"crossref","unstructured":"Sparrow JR. Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics Proc Natl Acad Sci U S A. 2016; 113: 4564\u20134569.","DOI":"10.1073\/pnas.1600474113"},{"key":"i1552-5783-59-11-4531-b68","doi-asserted-by":"crossref","unstructured":"Jin M, Li S, Moghrabi WN, Sun H, Travis GH. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell. 2005; 122: 449\u2013459.","DOI":"10.1016\/j.cell.2005.06.042"},{"key":"i1552-5783-59-11-4531-b69","doi-asserted-by":"crossref","unstructured":"Kubota R, Al-Fayoumi S, Mallikaarjun S, Patil S, Bavik C, Chandler JW. Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers. Retina. 2014; 34: 603\u2013609.","DOI":"10.1097\/01.iae.0000434565.80060.f8"},{"key":"i1552-5783-59-11-4531-b70","doi-asserted-by":"crossref","unstructured":"Dugel PU, Novack R, Csaky KG, Richmond PP, Birch DG, Kubota R. Phase II, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration. Retina. 2015; 35: 1173\u20131183.","DOI":"10.1097\/IAE.0000000000000606"},{"key":"i1552-5783-59-11-4531-b71","doi-asserted-by":"crossref","unstructured":"Rosenfeld PJ, Dugel PU, Holz FG, et al. Emixustat hydrochloride for geographic atrophy secondary to age-related macular degeneration [published online ahead of print April 28, 2018]. Ophthalmology. doi:10.1016\/j.ophtha.2018.03.059.","DOI":"10.1016\/j.ophtha.2018.03.059"},{"key":"i1552-5783-59-11-4531-b72","doi-asserted-by":"crossref","unstructured":"Caruso RC, Zujewski J, Iwata F, et al. Effects of fenretinide (4-HPR) on dark adaptation. Arch Ophthalmol. 1998; 116: 759\u2013763.","DOI":"10.1001\/archopht.116.6.759"},{"key":"i1552-5783-59-11-4531-b73","doi-asserted-by":"crossref","unstructured":"Kubota R, Al-Fayoumi S, Mallikaarjun S, Patil S, Bavik C, Chandler JW. Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers. Retina. 2014; 34: 603\u2013609.","DOI":"10.1097\/01.iae.0000434565.80060.f8"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2702317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:57Z","timestamp":1791927057000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,9,4]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24284","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,12]]}}}